DANIEL P. GOLD PHD - 25 May 2021 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role: Chief Executive Officer, Director
Signature: /s/ Brian G. Drazba, as attorney in fact
Issuer symbol: MEIP
Transactions as of: 25 May 2021
Net transactions value: +$12,600
Form type: 4
Filing time: 27 May 2021, 13:35:11 UTC
Next filing: 06 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEIP	Common Stock	Options Exercise	$12,600	+5,000	+1.1%	$2.52	458,632	25 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MEIP	Stock Option (Right to Buy)	Options Exercise	$0	-5,000	-0.74%	$0.000000	675,000	25 May 2021	Common Stock	5,000	$2.52	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.
F2	306,667 of the options are fully vested and currently exercisable. The remaining 368,333 options will vest in equal monthly installments through July 1, 2023.